Spred2 mRNA expression in CIS was as high as that in HGPUC, however; 75% of CIS showed negative membranous Spred2 staining and only 15% of CIS showed positive membranous Spred2 staining. The gene discussed is SPRED2; the disease is in situ carcinoma.